LINC02719

Across TCGA pan-cancer cohorts, LINC02719 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated LINC02719 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC02719 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02719 expression acts as an unfavorable survival marker, although some lineages such as UCS and PAAD show a favorable association.

MESO, LUAD, and TGCT are the cancer types where LINC02719 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.077	0.580	<.001	126	view →
LUAD	DFS	Tertile	IV	0.109	0.714	.001	36	view →
TGCT	DFS	Tertile	II,III,IV	0.088	0.917	.010	36	view →
SKCM	OS	Tertile	II,III,IV	0.664	0.861	.008	33	view →
UCS	DFS	Tertile	II,III,IV	1.000	0.235	.017	30	view →
LUSC	OS	Tertile	II,III,IV	0.196	0.615	.017	18	view →
PAAD	OS	Tertile	II,III,IV	1.000	0.417	.044	9	view →
LIHC	OS	Tertile	All	0.258	0.773	.018	9	view →
BLCA	DFS	Tertile	III,IV	1.000	0.271	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

LINC02719–MESO (OS)

Open the MESO breakdown →